Important Information for HEDIS® Users

Tweet about this on TwitterShare on LinkedIn0Share on Facebook0Share on Google+0Email this to someone

 

We have identified an issue with the (Asthma Controller Medications) list in the HEDIS® 2018 Medication List Directory (MLD) of NDC codes posted to the NCQA Web site on November 1, 2017. The list included codes for nebulizer medications that should not have been included.

The NDC codes for the nebulizer medications have been removed and the HEDIS 2018 MLD now has a correct version of the (Asthma Controller Medications) NDC list. Because we understand that this correction has implications for preliminary rate review of the asthma measures, we are informing as many HEDIS users as possible via this email, our Web site and on our blog.

To resolve the issue, our customers will have to update their Value Sets for both the Medication Management for People with Asthma (MMA) measure and Asthma Medication Ratio (AMR) measure.  Organizations working with these measures must download the updated table posted on the NCQA Web site on February 8, 2018.

We apologize for the inconvenience. Please submit any questions regarding this matter through the NCQA Policy Clarification Support (PCS) System.

 

Matt Brock
Matt Brock is the Director of Communications at NCQA. After more than two decades working in broadcast journalism, Matt now leads NCQA’s efforts to develop unique content that engages and informs consumers as well as providers, plans and policymakers via this blog, our website, NCQA.org and numerous social media platforms. Matt’s goal is to educate consumers and to direct them to the best resources when considering quality in their health care decisions.

Leave a Reply

Your email address will not be published. Required fields are marked *